Price is testing S1 support ($6.11) with deep value (P/B 0.73x), but technicals remain bearish (MACD divergence) and EBITDA is negative. The recent volume surge suggests accumulation, yet the long-term trend is negative below the 200-day SMA ($6.77). New entries are risky until a break above $6.32; maintain current exposure with a stop below the 50-day SMA ($5.80).